Igor Bilinsky - Net Worth and Insider Trading

Igor Bilinsky Net Worth

The estimated net worth of Igor Bilinsky is at least $57 dollars as of 2024-05-06. Igor Bilinsky is the Sr VP, Corporate Development of Fresh Tracks Therapeutics Inc and owns about 62 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $57. Details can be seen in Igor Bilinsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Igor Bilinsky has not made any transactions after 2015-07-13 and currently still holds the listed stock(s).

Transaction Summary of Igor Bilinsky

To

Igor Bilinsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Igor Bilinsky owns 5 companies in total, including Oncternal Therapeutics Inc (ONCT) , Armata Pharmaceuticals Inc (ARMP) , and Ignyta Inc (RXDX) among others .

Click here to see the complete history of Igor Bilinsky’s form 4 insider trades.

Insider Ownership Summary of Igor Bilinsky

Ticker Comapny Transaction Date Type of Owner
ONCT Oncternal Therapeutics Inc 2019-09-09 Chief Business Officer
ARMP Armata Pharmaceuticals Inc 2017-01-30 Chief Operating Officer
RXDX Ignyta Inc 2016-01-07 GM & Immuno-Oncology/SVP Sp Ops
2015-07-13 Senior VP & Corporate Dev't
2021-03-15 Chief Operating Officer

Igor Bilinsky Latest Holdings Summary

Igor Bilinsky currently owns a total of 1 stock. Igor Bilinsky owns 62 shares of Fresh Tracks Therapeutics Inc (FRTX) as of July 13, 2015, with a value of $57.

Latest Holdings of Igor Bilinsky

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FRTX Fresh Tracks Therapeutics Inc 2015-07-13 62 0.92 57

Holding Weightings of Igor Bilinsky


Igor Bilinsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Igor Bilinsky has made a total of 0 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years. The most-recent trade in Fresh Tracks Therapeutics Inc is the sale of 0 shares on July 13, 2015, which brought Igor Bilinsky around $881.

Insider Trading History of Igor Bilinsky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Igor Bilinsky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Igor Bilinsky Ownership Network

Ownership Network List of Igor Bilinsky

No Data

Ownership Network Relation of Igor Bilinsky


Igor Bilinsky Owned Company Details

What does Oncternal Therapeutics Inc do?

Who are the key executives at Oncternal Therapeutics Inc?

Igor Bilinsky is the Chief Business Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .

Oncternal Therapeutics Inc (ONCT) Insider Trades Summary

Over the past 18 months, Igor Bilinsky made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .

In summary, during the past 3 months, insiders sold 980 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,980 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.

Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncternal Therapeutics Inc Insider Transactions

No Available Data

Igor Bilinsky Mailing Address

Above is the net worth, insider trading, and ownership report for Igor Bilinsky. You might contact Igor Bilinsky via mailing address: C/o Vical Incorporated, 10390 Pacific Center Court, San Diego Ca 92121.

Discussions on Igor Bilinsky

No discussions yet.